Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’
Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla gets US FDA approval for Lopinavir and ritonavir oral pellets
These are used for the treatment of AIDS in infants and young children
Cipla, Serum Institute agreement
Signs exclusive distribution agreement for flu vaccine ‘Nasovac-S’ for India Cipla has signed an agreement with Serum Institute…
Cipla launches generic drug Sofosbuvir in India
The drug will be sold under the brand name ‘Hepcvir'
Cipla wins US$ 188.95 million of Global Fund ARV tender
The anti-retrovirals drugs will be manufactured in Cipla’s state-of-the-art manufacturing facilities in India, which has been…
Cipla’s arm Meditab sells stake in Jiangsu for $18.5 million
The closing of the transaction is subject to receipt of applicable regulatory approvals in China
Meda Pharmaceuticals and Cipla sue Apotex to enforce Dymista patents
Meda holds the NDA to manufacture and market Dymista in the US for the treatment of seasonal allergic rhinitis
Cipla in distribution agreement with SII for paediatric vaccines in Europe
The collaboration enables Cipla to enter into the vaccines segment